Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adriana Frigeri"'
Autor:
Natalia Ximena Garcia Basavilbaso, Maria Carolina Ballarino, Darío Bruera, Oscar D. Bruno, Alberto B. Chervin, Karina Danilowicz, Patricia Fainstein-Day, Silvina Gabriela Fidalgo, Adriana Frigeri, Mariela Glerean, Rodolfo Guelman, Gabriel Isaac, Debora Adela Katz, Pablo Knoblovits, Fabiana Librandi, Monica López Montes, Maria Susana Mallea-Gil, Marcos Manavela, Paula Mereshian, Daniel Moncet, Analia Pignatta, Amelia Rogozinsky, Laura R. Sago, Marisa Servidio, Monica Spezzi, Graciela Stalldecker, Julieta Tkatch, Nicolas Marcelo Vitale, Mirtha Guitelman
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 63, Iss 4, Pp 320-327
ABSTRACT Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, horm
Externí odkaz:
https://doaj.org/article/39ce9f9a76044f2fbe7a979e1fdb1177
Autor:
Analía Pignatta, Adriana Frigeri, Laura R. Sago, Natalia Garcia Basavilbaso, Marisa Servidio, Rodolfo Guelman, Nicolas Marcelo Vitale, Gabriel Isaac, Darío Bruera, Silvina Gabriela Fidalgo, Mirtha Guitelman, Oscar D. Bruno, Alberto Chervin, Paula Szafryk de Mereshian, Fabiana Librandi, Daniel Moncet, Marcos Manavela, Mariela Glerean, Monica Spezzi, Débora Katz, Pablo Knoblovits, Patricia Fainstein-Day, Julieta Tkatch, Graciela Stalldecker, Karina Danilowicz, Monica López Montes, Amelia Rogozinsky, Maria Carolina Ballarino, María Susana Mallea-Gil
Publikováno v:
Archives of Endocrinology and Metabolism, Volume: 63, Issue: 4, Pages: 320-327, Published: 22 AUG 2019
Archives of Endocrinology and Metabolism, Vol 63, Iss 4, Pp 320-327
Archives of Endocrinology and Metabolism v.63 n.4 2019
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Vol 63, Iss 4, Pp 320-327
Archives of Endocrinology and Metabolism v.63 n.4 2019
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, hormonal and
Autor:
Evangelina Giacoia, Adriana Graciela Díaz, Luisina Pieroni, H. Salerni, Beatriz Oliveri, A.M. Galich, Betiana Perez, Damian Robbiani, Silvina Tormo, Sabrina Lucas, Adriana Frigeri, Ariela Kitaigrodsky, María Auxiliadora Arce Lange, Silvia Kallsbrum, María Belén Zanchetta
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Journal of the Endocrine Society
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Journal of the Endocrine Society
Context:Hypoparathyroidism is a rare disease and as such, its natural history, long term complications and correct clinical management remain unclear.ObjectiveTo describe the natural history and clinical characteristics of the disease.Design and sett
Autor:
Adriana Graciela Díaz, Sabrina Lucas, Beatriz Oliveri, S. Tormo, H. Salerni, Evangelina Giacoia, Mariela Kitaigrodsky, Adriana Frigeri, Betiana Perez, Matias Grandjean, A.M. Galich, Silvia Kallsbrum, María Belén Zanchetta, Damian Robbiani
Publikováno v:
Journal of the Endocrine Society
Hypoparathyroidism (HPT) is a rare disorder characterized by hypocalcemia and absent or deficient PTH. Few data are available on the natural history and correct management of this disease. Aim: Describe clinical characteristics, treatment, and compli
Autor:
Roxana Fiasché, Francisco R Spivacow, Eduardo M. Kerzberg, JoséR. Zanchetta, Emilio J.A. Roldán, Adriana Frigeri
Publikováno v:
Current Therapeutic Research. 57:123-130
Oral pamidronate (APD) is being used increasingly in the treatment of a variety of bone diseases. In a retrospective chart review of patients at three research centers (a 558.3 patient-year sample), the side effects of treatment with oral, low-dose A